Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
NovaBay Pharma ( (NBY) ) has shared an announcement.
On January 20, 2026, NovaBay Pharmaceuticals entered into an at-the-market (ATM) sales agreement with Virtu Americas LLC, allowing the company to issue and sell up to $100 million of its common stock from time to time through Virtu acting as sales agent or principal, with sales to be conducted on the New York Stock Exchange or other existing trading markets under an effective shelf registration statement. NovaBay will pay Virtu a commission of up to 2.0% on gross proceeds from any stock sales, while retaining full discretion over whether, when and how much stock to sell, and either party may terminate the arrangement under specified conditions, giving the company a flexible mechanism to access additional equity capital as market conditions and corporate needs dictate.
The most recent analyst rating on (NBY) stock is a Hold with a $13.00 price target. To see the full list of analyst forecasts on NovaBay Pharma stock, see the NBY Stock Forecast page.
Spark’s Take on NBY Stock
According to Spark, TipRanks’ AI Analyst, NBY is a Neutral.
The score is held back primarily by weak financial performance (shrinking revenue, very large operating losses, and heavy cash burn). Technicals are the main offset with strong price momentum above key moving averages and a positive MACD. The recent large financing improves liquidity but raises dilution and strategy-risk, while valuation remains hard to justify due to a negative P/E and no dividend yield support.
To see Spark’s full report on NBY stock, click here.
More about NovaBay Pharma
NovaBay Pharmaceuticals, Inc. is a biopharmaceutical company whose common stock is listed and traded on the New York Stock Exchange, focusing on the development and commercialization of healthcare products within the pharmaceutical and life sciences industry.
Average Trading Volume: 1,335,100
Technical Sentiment Signal: Buy
Current Market Cap: $1.86B
For detailed information about NBY stock, go to TipRanks’ Stock Analysis page.